Covid-19 Vaccine Boosters Communications Toolkit

1y ago
12 Views
3 Downloads
3.03 MB
14 Pages
Last View : 1d ago
Last Download : 2m ago
Upload by : Helen France
Transcription

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITContentsIntroduction. 2Objective . 2Increasing the Rate of Older Ohioans Boosted Is Critical . 2Talking Points/Key Messages . 3Importance of COVID-19 Vaccine Boosters . 3Who Can Get a COVID-19 Booster Dose? . 4Mix-and-Match Boosters . 5Side Effects . 5Coadministration with Other Vaccines . 5Where to Get Vaccinated . 5Proof of Vaccination . 5Frequently Asked Questions About Boosters . 6Newsletter/Website Article Language . 7COVID-19 Boosters . 7Graphics and Artwork . 8Infographics . 8Printable Flyers . 9Trusted Resources and Links . 9Social Media Text and Graphics . 10Booster Eligibility . 10Importance of Boosters . 11Schedule a Booster Dose . 13Created March 18, 2022

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITIntroductionAs part of Ohio’s ongoing work to encourage Ohioans to get their COVID-19 booster shot, this communications toolkit has beendeveloped to provide tools that may be used to help promote key messages. Included in this introduction are key points aboutOhio’s efforts and specific recommended opportunities to ramp up efforts to encourage boosters throughout Ohio’scommunities.ObjectiveA hyper-local, hyper-personal effort to increase the number of boosters for Ohioans 50 years old and older.Increasing the Rate of Older Ohioans Boosted Is Critical Throughout the pandemic, age has been a leading predictor of risk from COVID-19. Older adults continue to be the mostat risk for severe complications or death from COVID-19. As of the latest Centers for Disease Control and Preventiondata assessing age-based risk, compared with 18- to 29-year-olds, the rate of death is 65 times higher for 65- to 74-yearolds; 140 times higher for those ages 75 to 84; and 340 times higher for people who are 85 years and older.The data leaves no question about the risks that come with age COVID-19 vaccine boosters are a powerful tool to reducerisk of hospitalization and death, especially among older Ohioans.The Messenger RNA (mRNA) COVID-19 vaccines from Pfizer-BioNTech and Moderna remained highly effective atpreventing severe outcomes from COVID-19 illness, including the need for ventilators and death, during the Omicronsurge, according to a new study released March 18 by the CDC. The study showed that the vaccines — and especially thebooster shot — protected most people from the worst outcomes. During the Omicron surge, the vaccine was 79 percenteffective in preventing death and hospitalization requiring ventilators for people who received the initial series of twodoses, and 94 percent effective for those people who had received a booster shot, according to the study. Over thewinter, Ohio experienced an unprecedented surge in COVID-19 cases driven by the Delta and Omicron variants hittingOhio in rapid succession. The surge led to previously unseen highs in cases, record-breaking hospitalizations, and a strainon healthcare infrastructure. It resulted in the postponement of many surgeries and medical procedures and requiredthe deployment of the Ohio National Guard as well as some federal support through FEMA to help with daily hospitaloperations and some testing sites.According to an earlier study published in the CDC’s Morbidity and Mortality Report, vaccine effectiveness againsthospitalization fell to 57 percent in people who had received their second dose more than six months earlier; however, athird shot restored that protection to 90 percent. A second study looked at nearly 10 million COVID-19 cases and morethan 117,000 deaths between April and December 2021. Cases and deaths were lower among people who had receiveda booster dose, compared with those who were fully vaccinated but did not receive a booster, and much lower than therates seen among unvaccinated people. Booster doses provided much larger gains in protection among people ages 65and older, followed by those ages 50 to 64, the study found. (Source: CDC, Jan. 28, 2022)To date more than 6.7 million Ohioans have completed their initial vaccine series, yet only about 3.4 million havereceived an additional dose, according to Ohio Department of Health data (March 21, 2022). That leaves several millionpeople who are likely eligible but missing out on the potential benefits of boosters.Approximately 36% of Ohioans age 65 and older have not received a booster shot, and 59% of those ages 50-64 yearshave not received a booster shot.

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITTalking Points/Key MessagesImportance of COVID-19 Vaccine Boosters A COVID-19 booster shot is an extra dose of the vaccine given after the protection provided by the original shot(s)decreases over time. Another dose can “boost” your immune system’s ability to fight the disease and maintain strongprotection from severe illness from COVID-19.COVID-19 vaccines are safe and effective at reducing risk for serious illness, hospitalization, and death from COVID-19.But that protection weakens over time, especially in people ages 65 and older. Getting a booster shot helps restore thatprotection, and is effective against variants such as Omicron.Age is the highest risk factor for COVID-19 serious illness. If you are over the age of 50, it is especially important toreceive a COVID-19 booster shot to reduce risk for serious illness, including hospitalization and death.In Ohio, approximately 96% of COVID-19 deaths have been among people age 50 and older (Source: Ohio Department ofHealth COVID-19 Mortality Metrics, March 21, 2022).Throughout the pandemic, age has been the leading predictor of risk from COVID-19. Older adults continue to be themost at risk for severe complications or death from COVID-19. Compared with adults younger than age 30, the rate ofdeath is 65 times higher for 65- to 74-year-olds; 140 times higher for those ages 75 to 84; and 340 times higher forpeople who are 85 years and older. (Source: Centers for Disease Control and Prevention Risk for COVID-19 Infection,Hospitalization, and Death by Age Group, March 9, 2022)Studies released by the CDC show that vaccines — and especially the booster shot — protected most people from theworst outcomes from COVID-19, even during the Omicron surge. During the recent surge, the mRNA COVID-19 vaccinesfrom Pfizer-BioNTech and Moderna were 79 percent effective in preventing death and hospitalization requiringventilators for people who received the initial series of two doses, and 94 percent effective for those people who hadalso received a booster shot, according to a new study released March 18 by the CDC. Data from two previous studiesshow COVID-19 vaccine boosters remain safe and continue to be highly effective against severe disease over time.Even though vaccination and booster rates are significantly higher in the older age groups compared with the youngergroups, there are still 25% of Ohioans age 65 and older who are not boosted, and lack that essential protection againstsevere outcomes from COVID-19 including hospitalizations and death. (Source: Ohio Department of Health COVID-19vaccine data analysis, March 2022)Many vaccines require booster shots to maintain protection. The frequency and intervals between doses vary from onetype of vaccine to another. The hepatitis B and shingles vaccines, for example, require boosters to achieve optimalimmunity. Tdap immunization against tetanus, diphtheria, and acellular pertussis requires a booster every 10 years topreserve immunity.The emergence of the highly contagious Omicron variant that led to record-shattering hospitalizations and cases in Ohiounderscores the importance of vaccination, boosters, and preventive efforts to protect against COVID-19, especially forthose at highest risk because of age.COVID-19 vaccination is the best way to protect yourself and your loved ones from COVID-19, including Omicron andfuture strains. The Centers for Disease Control and Prevention recommends that everyone 12 years old and older whohas completed the primary COVID-19 vaccination series receive a booster dose as soon as eligible.Booster doses are available for all three authorized vaccines in the United States (Pfizer-BioNTech, Moderna, Johnson &Johnson). The Pfizer and Johnson & Johnson booster doses are identical to the primary series dose. The Modernabooster is half of the original Moderna dose.The CDC recommends that you get vaccinated and boosted even if you previously had COVID-19 infection. Beforegetting a shot, be sure you have followed isolation and quarantine guidelines so you do not infect others, and discussyour COVID-19 history with your healthcare provider.

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITWho Can Get a COVID-19 Booster Dose? Millions of Americans age 12 and older are now eligible for booster rnaJohnson &JohnsonThose who originally received a two-dose series of either the Pfizer or Moderna vaccine can get a booster fivemonths after their last dose.Those who originally received the Johnson & Johnson vaccine can get a booster two months after their last dose.Those who are moderately to severely immunocompromised are eligible to get an additional dose with theirprimary vaccination series to strengthen the initial immune response, as well as a booster dose.AgeWhen to get a boosterBooster dose choicesEveryone 12years old andolder At least 5 months after completing the primaryCOVID-19 vaccination series.If moderately to severely immunocompromised, atleast 3 months after the primary series (whichincludes 3 doses). At least 5 months after completing the primaryCOVID-19 vaccination series.If moderately to severely immunocompromised, atleast 3 months after the primary series (whichincludes 3 doses). Pfizer-BioNTech or Moderna(mRNA COVID-19 vaccines)are preferred in mostsituations.*At least 2 months after receiving the originalJohnson & Johnson COVID-19 vaccination.If moderately to severely immunocompromised, atleast 2 months after receiving a second primaryseries dose of an mRNA COVID-19 vaccine. Pfizer-BioNTech or Moderna(mRNA COVID-19 vaccines)are preferred in mostsituations.* Adults 18years old andolder Adults 18years old andolder Pfizer-BioNTech or Moderna(mRNA COVID-19 vaccines)are preferred in mostsituations.*Teens 12–17 years old mayonly get a Pfizer-BioNTechCOVID-19 vaccine booster.*The Centers for Disease Control and Prevention recommends a messenger RNA COVID-19 vaccine (Pfizer-BioNTech or Moderna)for primary vaccination series and booster doses; however, the Johnson & Johnson vaccine can be given in some situations,including a severe reaction after an mRNA vaccine dose or allergies to ingredients in the mRNA vaccines.

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITMix-and-Match Boosters A COVID-19 booster dose does not have to match the vaccine given for the primary series. Vaccine recipients can choosewhich vaccine product to receive for their boost.The two COVID-19 mRNA vaccines have received full FDA approval and licensure. On Aug. 23, 2021, the FDA granted fulllicensure to the Pfizer-BioNTech COVID-19 vaccine for ages 16 and older. The vaccine will be marketed as Comirnaty.The vaccine is available for safe use under EUA for ages 12-15. On Jan. 31, 2022, the FDA granted full licensure to theModerna COVID-19 vaccine for ages 18 and older. The vaccine will be marketed as Spikevax.Three COVID-19 vaccines are available for use in the United States to prevent COVID-19. The CDC recommends PfizerBioNTech or Moderna (COVID-19 mRNA vaccines) for the primary vaccination series and booster following a thoroughreview of vaccine safety and effectiveness. Individuals may get Johnson & Johnson’s Janssen COVID-19 vaccine in somesituations, including known allergies to mRNA vaccine ingredients or past reactions to an mRNA vaccine.Side Effects Booster shot side effects are similar to those from second COVID-19 vaccine doses, and were mostly mild, moderate,and short-lived. Many people don’t experience side effects at all.Side effects are normal signs that your body is building protection. Some people have reported experiencing soreness orredness at the site of the injection, body aches, headaches, or fever, lasting for a day or two. These side effects shouldgo away in a few days, much like the side effects from other vaccines including the flu shot.Coadministration with Other VaccinesA COVID-19 vaccine can be given at the same time you receive another shot or vaccine, such as a flu shot, shingles vaccine, childimmunizations, or pneumonia vaccine.Where to Get Vaccinated Vaccines are widely available at many locations across the state, including local health departments, pediatricians, familyphysicians, community health centers, adult and children’s hospitals, and pharmacies. Ohioans are encouraged to calltheir provider for more information or visit gettheshot.coronavirus.ohio.gov or call 1-833-4-ASK-ODH (1-833-427-5634)to locate a provider or make an appointment.There is no out-of-pocket cost for a COVID-19 vaccine. Your provider may ask for your insurance, Medicare, or Medicaidinformation, because providers can charge an administration fee to insurance. You will not have to pay a fee directly.Proof of VaccinationBring your CDC COVID-19 Vaccination card with you to your appointment if you need another shot of COVID-19 vaccine so yourprovider can fill in the information about your additional shot. If you cannot find your vaccine card, you should first contact youroriginal vaccine provider to see if they can locate your records. If they are unable to assist, please contact your local healthdepartment. If they are unable to assist, please review this information on how to mail a request for your vaccination records tothe Ohio Department of Health. You will not be able to obtain a new vaccine card by request, but will be able to access yourvaccination records. If you do not have your card, you can still get your booster dose.This document is available on the ODH Coronavirus website regarding immunization e/requesting-vaccination-records.pdf

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITFrequently Asked Questions About BoostersQ: What’s the difference between a “primary series,” an “additional” dose, and a “booster” dose?A: A primary series is generally an initial two-dose series of an mRNA COVID-19 vaccine (Pfizer or Moderna) or a single dose ofJohnson & Johnson vaccine. An additional dose can be given after the second dose of Moderna or Pfizer, and the first dose ofJohnson & Johnson, to people who likely did not have a protective immune response to the initial vaccination. This additionaldose is recommended for moderately to severely immunocompromised people. A booster dose is given to people who havereceived a primary series. The intent is to boost immunity because protection is likely to have waned over time.Q: If we need booster doses, does this mean the COVID-19 vaccines are no longer effective?A: No. The COVID-19 vaccines continue to be remarkably effective at reducing risk of severe disease, hospitalization, and deathfrom COVID-19, and continue to offer protection against variants. Protection against severe illness and death was the originalgoal of vaccines. A booster dose could help fully vaccinated people at greater risk maintain the highest protection over time, anddata suggests that boosters help broaden and strengthen protection against Omicron and other variants. People who receivedtheir initial vaccine series will experience waning immunity over time. Receiving a timely booster dose when you are eligiblerestores those antibody levels and provides significant protection.Q: Are booster shots the same as the main vaccines?A: Yes. COVID-19 booster shots are the same products used during the initial vaccinations. There are no separate boosterproducts. However, in the case of the Moderna COVID-19 vaccine booster shot, the dose is half of the amount of the vaccinepeople get for their primary series, but is drawn from the same vials.Q: Are the side effects worse for the booster?A: Adults and children may have some side effects from a COVID-19 vaccine including pain, redness or swelling at the injectionsite, tiredness, headache, muscle pain, chills, fever and nausea. Serious side effects are rare, but may occur.Q: Am I still fully vaccinated if I haven’t gotten a booster?A: Yes, a person is still considered fully vaccinated two weeks after the second dose in a two-shot series, such as the PfizerBioNTech or Moderna vaccines, or two weeks after a single-dose vaccine, such as the Johnson & Johnson vaccine. Fullyvaccinated does not mean optimally protected. To be optimally protected and up to date on their recommended COVID-19vaccinations, a person needs to get a booster shot when eligible.Q: What is considered “up to date” on COVID-19 vaccinations?A: Everyone is considered up to date until the time they are eligible for another dose. Fully vaccinated individuals are eligible for abooster 5 months after the second dose in a two-shot series, (Pfizer-BioNTech or Moderna vaccines), or two months after theJ&J/Janssen vaccine. A person would need to get a booster shot to be considered up to date.Q: When will we need another booster dose?A: Vaccine makers Pfizer-BioNTech and Moderna have asked the U.S. Food & Drug Administration to authorize a second boosterdose of the COVID-19 vaccine. Pfizer’s request is for people age 65 and older who are at higher risk for severe illness for COVID19. Moderna’s request is for all adults. Before additional doses can be given, the FDA and CDC would have to authorize doses,recommend their use, and define eligibility criteria.

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITNewsletter/Website Article LanguageThe following text can be customized for use on your website or in newsletters.COVID-19 BoostersPossible Subject Line: Stay Up To Date on COVID-19 VaccinationsAs the COVID-19 pandemic evolves, ongoing protection remains as critical as ever. Our best defense has been and will continueto be staying up to date on COVID-19 vaccinations by getting a booster dose when eligible.COVID-19 vaccines are remarkably effective at reducing risk for serious illness, hospitalization, and death. But protection weakensover time, especially in people ages 65 and older. Getting a booster shot helps restore that protection, and is effective againstvariants such as Omicron.Throughout the pandemic, age has been the leading predictor of risk from COVID-19. Older adults continue to be the most at riskfor severe complications or death from COVID-19. Compared with adults younger than age 30, the rate of death is 65 timeshigher for 65- to 74-year-olds; 140 times higher for those ages 75 to 84; and 340 times higher for people who are 85 years andolder, according to the Centers for Disease Control and Prevention’s Risk for COVID-19 Infection, Hospitalization, and Death byAge Group.Millions of eligible Ohioans are not vaccinated or boosted. If you are over the age of 50, it is especially important to receive aCOVID-19 booster shot to reduce your risk for serious illness, including hospitalization and death. Cases and hospitalizationscontinue on a downward trend; however, the COVID-19 threat remains.A booster dose of the COVID-19 vaccine is recommended for all Ohioans age 12 and older when eligible: Johnson & Johnson recipients can get a booster two months after they received their first dose of the vaccine. Pfizer and Moderna recipients can get a booster five months after their last dose.Ohioans who have questions about COVID-19 vaccines and boosters are encouraged to contact their healthcare provider formore information.

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITGraphics and ArtworkInfographicsClick to download.Click to download.Click to download.

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITPrintable FlyersClick to download flyer.Click to download flyer.Click to download flyer.Click to download flyer.Trusted Resources and Links Recommended articles:o Washington Post: Vaccines remained highly effective at preventing serious illness and death during Omicronsurge, CDC report sayso The Atlantic: The COVID Strategy America Hasn’t Really Triedo The New York Times: As Omicron Crests, Booster Shots Are Keeping Americans Out of Hospitals Ohio Department of Health COVID-19 Vaccine website - https://coronavirus.ohio.gov/vaccineo Fact Sheet COVID-19 Vaccine Booster Doseso Frequently Asked Questions COVID-19 Vaccine Booster Doseso COVID-19 Vaccine Booster Dose Eligibilityo Do I Need an Additional COVID-19 Vaccine Shot?o Fact sheet: Additional Vaccine Doses for the Immunocompromisedo COVID-19 Fact Sheet: Safety and effectiveness of COVID-19 vaccineso What to know before, during, and after receiving a COVID-19 vaccineo Acceptable Forms of ID for Vaccine Appointmentso COVID-19 Vaccine Provider Information Centers for Disease Control and Prevention Resourceso Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation andDeath — United States, March 2021–January 2022o Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department andUrgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron VariantPredominance — VISION Network, 10 States, August 2021–January 2022o COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and WithoutBooster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021o Risk for COVID-19 Infection, Hospitalization, and Death by Age Groupo Vaccinate with Confidence Resourceso Communication Resources for COVID-19 Vaccineso Benefits of Getting a COVID-19 Vaccineo COVID-19 Vaccine Booster Shotso COVID-19 Vaccines are Available at No Cost to the Publico Stay Up to Date with Your COVID-19 Vaccines

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITSocial Media Text and GraphicsBooster EligibilityFacebookAre you eligible for a COVID-19 booster?You must be 12 and either: Had your single dose of the J&Jvaccine at least 2 months ago OR Completed the Pfizer or Modernavaccine series (2 doses) at least 5months ago.Learn more or book your appointmentat gettheshot.coronavirus.ohio.gov.TwitterAre you eligible for a #COVID19#booster?You must be 12 and either: Had your single dose of the J&Jvaccine at least 2 months ago OR Completed the Pfizer or Modernavaccine series (2 doses) at least 5months ago.Learn more or book your appointmentat gettheshot.coronavirus.ohio.gov.InstagramAre you eligible for a COVID-19 booster?You must be 12 and either Had your single dose of the J&Jvaccine at least 2 months ago OR Completed the Pfizer or Modernavaccine series (2 doses) at least 5months ago.Learn more or book your appointmentat gettheshot.coronavirus.ohio.gov.#gettheshot #COVID19 #fightcovid19#getboostedClick to download graphic.Click to download graphic.Click to download graphic.Is it time for your COVID-19 vaccinebooster? Stay up to date on yourCOVID-19 vaccinations for optimalprotection. Learn more about COVID-19 boostereligibility athttps://bit.ly/OHBoosterInfo. Book an appointment atgettheshot.coronavirus.ohio.gov.Is it time for your #COVID19 #booster?Stay up to date on your COVID-19vaccinations for optimal protection. Learn more about booster eligibilityat https://bit.ly/OHBoosterInfo. Book an appointment atgettheshot.coronavirus.ohio.gov.Is it time for your COVID-19 vaccinebooster? Stay up to date on yourCOVID-19 vaccinations for optimalprotection. Learn more about COVID-19 boostereligibility athttps://bit.ly/OHBoosterInfo. Book an appointment atgettheshot.coronavirus.ohio.gov.#gettheshot #COVID19 #fightcovid19#getboostedClick to download graphic.Click to download graphic.Click to download graphic.

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITIs it time for your COVID-19 vaccinebooster? If you are moderately toseverely immunocompromised, youmay be eligible for additional doses andboosters to strengthen your protection. Learn more:https://bit.ly/OHimmunocompromised Book an appointment:gettheshot.coronavirus.ohio.gov.Is it time for your #COVID19 #booster?If you are moderately to severelyimmunocompromised, you may beeligible for additional doses andboosters to strengthen your protection. Learn more:https://bit.ly/OHimmunocompromised Book an appointment:gettheshot.coronavirus.ohio.gov.Is it time for your COVID-19 vaccinebooster? If you are moderately toseverely immunocompromised, youmay be eligible for additional doses andboosters to strengthen your protection. Learn more:https://bit.ly/OHimmunocompromised Book an eshot #COVID19 #fightcovid19#immunocompromised #getboostedClick to download graphic.Click to download graphic.Click to download graphic.Age is the highest risk factor for seriousillness from #COVID19. If you are overthe age of 50, it is especially importantto receive a COVID-19 #booster shot toreduce risk for serious illness, includinghospitalization and death.https://bit.ly/OHBoosterInfo.Age is the highest risk factor for seriousillness from COVID-19. If you are overthe age of 50, it is especially importantto receive a COVID-19 booster shot toreduce risk for serious illness, includinghospitalization and death.https://bit.ly/OHBoosterInfo.#gettheshot #COVID19 #fightcovid19#getboostedImportance of BoostersAge is the highest risk factor for seriousillness from COVID-19. If you are overthe age of 50, it is especially importantto receive a COVID-19 booster shot toreduce risk for serious illness, includinghospitalization and death.https://bit.ly/OHBoosterInfo.Click to download.Click to download.Click to download.

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKITCOVID-19 vaccines are safe andeffective at reducing risk for seriousillness, hospitalization, and death fromCOVID-19. But that protection weakensover time, especially in people ages 65and older. Get boosted to restore thatprotection.ℹ: https://bit.ly/OHBoosterInfo.Click to download.Older adults face the highest risk forsevere illness from COVID-19.Compared with adults younger than age30, the rate of death is 65 times higherfor ages 65-74; 140 times higher forages 75-84; and 340 times higher forpeople who are age 85 and older.ℹ: https://bit.ly/OHBoosterInfo.Click to download.#COVID19 vaccines are safe andeffect

COVID-19 VACCINE BOOSTERS COMMUNICATIONS TOOLKIT . Talking Points/Key Messages . Importance of COVID-19 Vaccine Boosters A COVID-19 booster shot is an extra dose of the vaccine given after the protection provided by the original shot(s) decreases over time.

Related Documents:

Costa Rica Vaccine Trial A community-based, randomized trial 7,466 Women 18-25 yo Enrolled (06/04 – 12/05) Hepatitis A Vaccine HPV-16/18 Vaccine Vaccine Dose 1 Vaccine Dose 2 Vaccine Dose 3 Vaccine Dose 1 Vaccine Dose 2 Vaccine Dose 3 6 Months COMPLETED CENSUS

Is the COVID-19 vaccine safe for children? The focus of COVID-19 vaccine development has been on adults. Pfizer’s vaccine has been authorized for ages 16 and up. Moderna’s vaccine is currently authorized for ages 18 and up. Will a COVID-19 vaccine alter my DNA? No. The COVID-19 va

26) How should I counsel patients who are concerned about TTS or GBS following receipt of the Johnson & Johnson COVID-19 vaccine? 27 27) Is it true that people in the COVID-19 vaccine clinical trials died? 27 28) How will the safety of the COVID-19 vaccines be monitored? 28 29) Is the COVID-19 vaccine being studied in children or pregnant women? 28

Frequently Asked Questions Table of Contents Vaccine Development and Approval 6 1) Is there a vaccine that protects against COVID-19 (SARS-CoV-2)? 6 2) When did COVID-19 vaccines become available? 6 3) Why is the COVID-19 vaccine development timeline so condensed compared to when other

COVID-19 Vaccine AstraZeneca is an adenovirus vector vaccine which received a conditional marketing authorisation in the EU on 29 January 2021 for active immunisation against COVID-19 in individuals 18 years of age and older. Cases of thromboembolic events have been reported following administration of COVID-19 Vaccine

Essential to support vaccine implementation planning – Challenging due to incomplete information on vaccine safety and efficacy in population subgroups and vaccine dose availability Prioritization framework for COVID -19 vaccines adapted from 2018 pandemic influenza vaccine guid

COVID-19 Vaccination” means a CDC vaccine card or a vaccine record from the New Mexico Statewide Immunization Information System, indicatingthe name of the vaccine recipient, the date(s) the vaccine was administered, and which COVID-19 vaccine was a

ASME 2019 Updates 2.27.1.1.1 A communications means between the car and a location staffed by authorized personnel who can take appropriate action shall be provided. 2.27.1.1.3 The communications means within the car shall comply with the following requirements: a) In jurisdictions enforcing NBCC, Appendix E of ASME A17.l/CSA B44, or in jurisdictions not enforcing NBCC, ICC/ ANSI A117.1, ADAAG .